Qiagen opens new office in Malaysia

QIAGEN has opened a principal office in Malaysia, QIAGEN Biotechnology Malaysia, to serve its growing base of customers for 'sample to insight' solutions, enabling them to help fight diseases using molecular diagnostics, break new ground in research for the life sciences and pharmaceutical industry, and protect the public through food safety and forensics testing applications.

"Opening this new office marks a milestone for QIAGEN. We have grown rapidly in Malaysia since 2006. Our expansion is gaining momentum as we serve Malaysia's doctors, hospitals and diagnostic laboratories, university researchers, growing biotech and pharma industry, and other labs," said Ian Martin, Vice President Asia Pacific of QIAGEN. "We have many initiatives, such as a partnership with the Malaysian Ministry of Health to enhance cervical cancer screening, work with tuberculosis control authorities to protect high-risk individuals from active TB, and support for reliable food testing such as ensuring halal integrity. QIAGEN's mission is to make improvements in life possible, and we appreciate the welcoming business environment in Malaysia."

QIAGEN's sales in Malaysia are expanding at strong double-digit rates, contributing to the company's growth in emerging markets around the world. Molecular diagnostics solutions, in particular, are gaining widespread acceptance in Malaysian healthcare. QIAGEN entered the country by acquiring Research Biolab Malaysia in 2006 and has since expanded, especially into clinical testing solutions.